- Fee assured
- Verified this account
I am Consultant Nephrologist at the Richard Bright Renal Unit in Southmead Hospital, Bristol and Honorary Senior Lecturer at the University of Bristol and Imperial College London. I graduated from Gonville & Caius College, Cambridge and completed nephrology training at the Hammersmith Hospital, London. I was awarded an MD in Nephrology at Imperial College London and remain active in clinical research with a special interest in end-stage renal disease, dialysis and cerebrovascular disease.
I have comprehensive experience in the management of glomerular disease and vasculitis, lupus nephritis, and complex hypertension, maintenance dialysis and renal transplantation and the provision of acute renal care.
I am presently Strategic Director for the Vascular, Renal & Transplant Networks, ASCR Division, North Bristol NHS Trust, and Clinical Lead for Haemodialysis and Clinical Research at the Richard Bright Renal Unit and NIHR: West of England Lead for Renal Disorders. Throughout clinical practice and my research I aim to improve treatments and outcomes of patients with kidney disease.
Areas of interest
General nephrology; Chronic kidney disease (CKD); Diabetic renal disease; Glomerulonephritis; Vasculitis and renal manifestations of Connective Tissue Disease; SLE; Hypertension; Dialysis (peritoneal dialysis / haemodialysis); Nephro-urology; Renal Transplantation
- Bristol University Web Page: http://www.bristol.ac.uk/clinical-sciences/people/albert-power/overview.html
- Imperial College London Web Page: http://www.imperial.ac.uk/people/a.power08
- North Bristol NHS Trust Web Page: https://www.nbt.nhs.uk/our-services/a-z-consultants/dr-albert-power
- Bristol Kidney Care: http://www.bristolkidney.co.uk
Current NHS consultant posts held
Richard Bright Renal Unit
North Bristol NHS Trust
I have an active research portfolio examining the pathogenesis of cerebrovascular disease in patients with advanced renal impairment. Current work is focused on stroke pathophysiology & outcomes in patients with renal disease through regional initiatives, national studies in collaboration with the UK Renal Registry and global research through the MONDO consortium under the auspices of the Renal Research Institute based in New York.
ERA-EDTA / EURODOPPS Grant 2015 - Effect of stroke on quality of life of haemodialysis patients
RRI Scientist-in-Residence [2014 & 2015]
Association between pre hemodialysis serum sodium concentration and blood pressure: results from a retrospective analysis from the international monitoring dialysis outcomes (MONDO) initiative. J Hum Hypertens (2015)
Incidence, risk factors and outcomes of stroke post-transplantation in patients receiving a steroid-sparing immunosuppression protocol.
Clin Transplant (2015); 29:18-25.
Comparison of Tesio and LifeCath Twin Permanent Hemodialysis Catheters: The VyTes Randomised Trial. Power A. et al. J Vasc Access (2014); 15:108-115.
Acute Stroke Thrombolysis in End-Stage Renal Disease: A National Survey of Nephrologist Opinion. Power A. et al. Nephron Clin Pract (2013); 124:167-172.
Stroke in Dialysis and Chronic Kidney Disease
Power A. Blood Purif (2013); 36:179-183.
Screening for Transient Ischemic Attack in Hemodialysis. J Nephrol (2013); 26(5):919-924.
Renal Impairment Reduces the Efficacy of Thrombolytic Therapy in Acute Ischemic Stroke. Cerebrovasc Dis (2013); 35(1):45-52.
Appraising Stroke Risk in Maintenance Hemodialysis: A Large Single-center Cohort Study. Am J Kidney Dis (2012); 59(2):249-257.
Intracranial arterial calcification is highly prevalent in hemodialysis patients but does not associate with acute ischemic stroke. Hemodial Int (2011); 15(2):256-263.
Long-term Tesio catheter access for haemodialysis can deliver high dialysis adequacy with low complication rates. J Vasc Interv Radiol (2011); 22:631-637.
High but stable incidence of subdural haematoma in haemodialysis – a single-centre study. Nephrol Dial Transplant (2010); 25(7):2272-2275.
Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging. Clin J Am Soc Nephrol (2010); 5(3):484-489.
Translumbar central venous catheters for long-term haemodialysis. Nephrol Dial Transplant (2010); 25(5):1588-1595.
Bacteremia associated with tunneled hemodialysis catheters: outcome after attempted salvage. Clin J Am Soc Nephrol (2009); 4(10):1601-1605.
Advances and Innovations in Dialysis in the 21st Century. Postgrad Med J (2009); 85(1000):102-107.
Sodium Citrate versus Heparin Catheter Locks for Cuffed Central Venous Catheters: A Single-Centre Randomized Controlled Trial. Power A. et al. Am J Kidney Dis (2009); 53(6): 1034-1041.
Courses offered to GPs
CKD – managing anaemia
Overview of NICE CKD guidelines for general practice
Caring for the dialysis patient in primary care
- BA University of Cambridge 1995
- MB BChir University of Cambridge 1997
- MA University of Cambridge 1999
- MRCGP Royal College of General Practitioners 2004
- MRCP (UK) Royal College of Physicians 2005
- MD (Res) Imperial College London 2012
Reference number 4476362
Affiliations / memberships
UK Renal Association
European Renal Association - European Renal & Transplant Association
International Society of Nephrology
American Society of Nephrology
National Kidney Federation
International Society for Peritoneal Dialysis
International Society for Blood Purification
- BMI Bath Clinic
- 18:00 - 20:00
- 0117 980 4118
- Bristol Urology Associates85 Alma...
- 09:30 - 11:00
- 0117 980 4118
- The GlenRedland HillDurdham DownBRISTOLBS6 6UT
- 17:00 - 19:00
- 0117 980 4118
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.